ELTX
Elicio Therapeutics Inc.
$10.61
-$0.16(-1.49%)
32
Overall
40
Value
30
Tech
26
Quality
Market Cap
$154.40M
Volume
159.93K
52W Range
$5.80 - $14.93
Target Price
$17.33
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $27.5M | $2.3M | -- | -- | -- | ||
| Total Revenue | $28.3M | $2.3M | -- | -- | -- | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $433.0K | -- | -- | -- | -- | ||
| GROSS PROFIT | |||||||
| Gross Profit | $27.9M | $2.3M | -- | -- | -- | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $67.6M | $23.7M | $35.7M | $45.0M | $37.7M | ||
| Research & Development | $48.7M | $18.1M | $23.8M | $33.7M | $24.9M | ||
| Research Expense | $48.7M | $18.1M | $23.8M | $33.7M | $24.9M | ||
| Selling, General & Administrative | $18.5M | $5.6M | $11.9M | $11.3M | $12.8M | ||
| General & Administrative Expenses | $18.5M | $5.6M | $11.9M | $11.3M | $12.8M | ||
| Salaries & Wages | -- | -- | $1.2M | -- | -- | ||
| Depreciation & Amortization | $100.0K | $400.0K | $400.0K | $300.0K | -- | ||
| Depreciation & Amortization | $100.0K | $400.0K | $400.0K | -- | -- | ||
| Amortization | -- | -- | -- | $75.0K | -- | ||
| Other Operating Expenses | $433.0K | $1.2M | $1.5M | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-39.3M | $-23.7M | $-35.7M | $-45.0M | $-37.7M | ||
| EBITDA | $-50.0M | $-30.8M | $-44.9M | $-50.2M | $-37.1M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $1.8M | $3.6M | $1.1M | $455.0K | $1.1M | ||
| Intinc | -- | $65.0K | $373.0K | $777.0K | -- | ||
| Net Non-Operating Interest Income/Expense | $-1.8M | $-3.5M | $-686.0K | $-455.0K | $-1.1M | ||
| Gain on Sale of Securities | -- | $-945.0K | $429.0K | -- | -- | ||
| Other Income/Expense | $12.4M | $943.0K | $-1.0M | $3.1M | $1.9M | ||
| Other Special Charges | $-4.8M | $2.0K | $603.0K | $-3.1M | $-1.9M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | -- | $9.2M | -- | -- | -- | ||
| Special Income Charges | -- | $-9.2M | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | $3.0M | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-52.7M | $-31.9M | $-46.1M | $-51.4M | $-38.4M | ||
| Pre-Tax Income | $-54.6M | $-28.2M | $-34.5M | $-48.4M | $-40.8M | ||
| INCOME TAX | |||||||
| Tax Provision | $-5.5M | $-7.3M | $-10.9M | -- | -- | ||
| NET INCOME | |||||||
| Net Income | $-54.6M | $-28.2M | $-35.2M | $-51.9M | $-39.6M | ||
| Net Income (Continuing Operations) | $-54.6M | $-28.2M | $-35.2M | $-51.9M | $-39.6M | ||
| Net Income (Discontinued Operations) | $-54.6M | $-28.2M | $-35.2M | $-51.9M | $-39.6M | ||
| Net Income (Common Stockholders) | $-54.6M | $-28.2M | $-35.2M | $-51.9M | $-39.6M | ||
| Normalized Income | $-60.0M | -- | -- | -- | $-40.4M | ||
| TOTALS | |||||||
| Total Expenses | $68.1M | $23.7M | $35.7M | $45.0M | $37.7M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $2.8M | $3.0M | $5.1M | $12.2M | $15.3M | ||
| Average Shares Outstanding (Diluted) | $2.8M | $3.0M | $5.1M | $12.2M | $15.3M | ||
| Shares Outstanding | $30.0M | $30.1M | $10.2M | $16.0M | $18.4M | ||
| Basic EPS | $-19.3 | $-12.9 | $-6.96 | $-4.25 | $-2.58 | ||
| Basic EPS (Continuing Operations) | $-19.3 | $-12.9 | $-6.96 | $-4.25 | $-2.58 | ||
| Diluted EPS | $-19.3 | $-12.9 | $-6.96 | $-4.25 | $-2.58 | ||
| Diluted EPS (Continuing Operations) | $-19.3 | $-12.9 | $-6.96 | $-4.25 | $-2.58 | ||
| OTHER METRICS | |||||||
| Earnings from equity interest | $-99.0K | $151.0K | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $-99.0K | $151.0K | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | $3.0K | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | $3.0K | -- | ||
| Other Gand A | $18.5M | $5.6M | $11.9M | $11.3M | $12.8M | ||
| Restruct | -- | $9.2M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELTX | $10.61 | -1.5% | 159.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Elicio Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW